Updated January 21 at 12:27am
Life Sciences
28 results total, viewing 21 - 28
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. more
The University of Massachusetts was granted 62 utility patents in 2015, putting the school at No. 30 on a list of the Top 100 worldwide universities that were granted U.S. patents. more
(Updated, 6:15 p.m.) Ventas Inc., a real estate investment trust with more than 1,300 properties, has announced its intention to purchase substantially all of the assets of Wexford Science & Technology LLC. more
More than $480,000 has been awarded by the Rhode Island Foundation in seed funding for 20 medical research projects. more
Alexion Pharmaceuticals Inc. fell the most in six years after the company’s drug for a rare neuromuscular disease failed to meet its primary goal in a final-stage trial. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
« Prev | 1 | 2 | 3